J
Joanne M. Langley
Researcher at Nova Scotia Health Authority
Publications - 275
Citations - 9293
Joanne M. Langley is an academic researcher from Nova Scotia Health Authority. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 49, co-authored 252 publications receiving 7832 citations. Previous affiliations of Joanne M. Langley include Saint John Regional Hospital & Dalhousie University.
Papers
More filters
Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women
Simon Dobson,Shelly A. McNeil,Marc Dionne,Meena Dawar,Gina Ogilvie,Mel Krajden,Chantal Sauvageau,David W. Scheifele,Tobias R. Kollmann,Scott A. Halperin,Joanne M. Langley,Julie A. Bettinger +11 more
TL;DR: In this paper, the authors compared the effect of two and three doses of the quadrivalent human papillomavirus (HPV) vaccine to women who received three and six months of the vaccine within 6 months, respectively.
Journal ArticleDOI
2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.
Andi L. Shane,Rajal K. Mody,John A. Crump,Phillip I. Tarr,Theodore S. Steiner,Karen L. Kotloff,Joanne M. Langley,Christine Wanke,Cirle A. Warren,Allen C. Cheng,Joseph B. Cantey,Larry K. Pickering +11 more
TL;DR: These guidelines are intended for use by healthcare professionals who care for children and adults with suspected or confirmed infectious diarrhea and are not intended to replace physician judgement regarding specific patients or clinical or public health situations.
Journal ArticleDOI
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.
Simon Dobson,Shelly A. McNeil,Marc Dionne,Meena Dawar,Gina Ogilvie,Mel Krajden,Chantal Sauvageau,David W. Scheifele,Tobias R. Kollmann,Scott A. Halperin,Joanne M. Langley,Julie A. Bettinger,Joel Singer,Deborah Money,Dianne Miller,Monika Naus,Fawziah Marra,Eric W. Young +17 more
TL;DR: Among girls who received 2 doses of HPV vaccine 6 months apart, responses to HPV-16 and HPV-18 one month after the last dose were noninferior to those among young women who received 3 doses of the vaccine within 6 months.
Journal ArticleDOI
The impact of vaccination on COVID-19 outbreaks in the United States.
Seyed M. Moghadas,Thomas N. Vilches,Kevin Zhang,Chad R. Wells,Affan Shoukat,Burton H. Singer,Lauren Ancel Meyers,Kathleen M. Neuzil,Joanne M. Langley,Meagan C. Fitzpatrick,Alison P. Galvani +10 more
TL;DR: In this article, the authors evaluated the impact of a 2-dose COVID-19 vaccination campaign on reducing incidence, hospitalization, and deaths in the United States (US) by developing an agent-based model of SARS-CoV-2 transmission.
Journal ArticleDOI
Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers
Shelly A. McNeil,Scott A. Halperin,Joanne M. Langley,Bruce Smith,Andrew E. Warren,Geoffrey P. Sharratt,Darlene M. Baxendale,Mark A. Reddish,Mary C. Hu,Steven D. Stroop,Janine Linden,Louis Fries,Peter Vink,James B. Dale +13 more
TL;DR: On the basis of epidemiological data demonstrating that the majority of cases of pharyngitis, necrotizing fasciitis, and other invasive streptococcal infections are caused by a limited number of serotypes, this 26-valent vaccine could have significant impact on the overall burden of streptitiscal disease.